⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BTAI News
BioXcel Therapeutics, Inc. Common Stock
Prevent Blindness Declares May as Third Annual Inherited Retinal Disease and Genetic Testing Month, Offering Resources to Public and Healthcare Allies, to Help Save Sight
prnewswire.com
BTAI
ALKS
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
globenewswire.com
BTAI
Form 8-K
sec.gov
BTAI
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
globenewswire.com
BTAI
Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
BTAI
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
globenewswire.com
BTAI
Mosaic Therapeutics nomme Vince O’Neill au poste de directeur de la R&D
businesswire.com
BTAI
SNY
GSK
BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
globenewswire.com
BTAI
Form 8-K
sec.gov
BTAI
Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D
businesswire.com
BTAI
MRNA